Harmaline: a competitive inhibitor of Na ion in the (Na+ + K+)-ATPase system.
D000200:Action Potentials; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000201:enzymology; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D002852:Chromatography, Ion Exchange; D049832:Decapodiformes; D004912:Erythrocytes / Q000201:enzymology; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D007700:Kinetics; D008566:Membranes / Q000187:drug effects / Q000201:enzymology; D010761:Phosphorus Radioisotopes; D011725:Pyridines / Q000494:pharmacology; D011868:Radioisotopes; D051381:Rats; D012160:Retina / Q000201:enzymology; D012964:Sodium / Q000378:metabolism*; D012975:Sodium Isotopes
D000470:Alkaloids; D006213:Hallucinogens; D007211:Indoles; D010761:Phosphorus Radioisotopes; D011725:Pyridines; D011868:Radioisotopes; D012975:Sodium Isotopes; D012964:Sodium; D000251:Adenosine Triphosphatases